학술논문
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
Document Type
Article
Author
Haynes, Richard; Valdes-Marquez, Elsa; Hopewell, Jemma C.; Chen, Fang; Li, Jing; Parish, Sarah; Landray, Martin J.; Armitage, Jane; Collins, R.; Armitage, J.; Baigent, C.; Chen, Z.; Landray, M.J.; Chen, Y.; Jiang, L.; Pedersen, T.; Bowman, L.; Haynes, R.; Rahimi, K.; Tobert, J.; Sleight, P.; Simpson, D.; Parish, S.; Baxter, A.; Lay, M.; Bray, C.; Wincott, E.; van Leijenhorst, G.; Mitchel, Y.; Kuznetsova, O.
Source
In Clinical Therapeutics September 2019 41(9):1767-1777
Subject
Language
ISSN
0149-2918